Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France.
COVID-19
RSV
SARI
SARS-CoV-2
bronchiolitis
disease burden
non-pharmacological interventions
pharmacological interventions
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
entrez:
23
7
2021
pubmed:
24
7
2021
medline:
31
7
2021
Statut:
ppublish
Résumé
The Rhône-Loire metropolitan areas' 2020/21 respiratory syncytial virus (RSV) epidemic was delayed following the implementation of non-pharmaceutical interventions (NPI), compared with previous seasons. Very severe lower respiratory tract infection incidence among infants ≤ 3 months decreased twofold, the proportion of cases among children aged > 3 months to 5 years increased, and cases among adults > 65 years were markedly reduced. NPI appeared to reduce the RSV burden among at-risk groups, and should be promoted to minimise impact of future RSV outbreaks.
Identifiants
pubmed: 34296674
doi: 10.2807/1560-7917.ES.2021.26.29.2100630
pmc: PMC8299747
doi:
Banques de données
ClinicalTrials.gov
['NCT04944160']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Antoine Ouziel
(A)
Jean-Claude Tardy
(JC)
Pascal Gaucherand
(P)
Luc Panetta
(L)
Jerome Massardier
(J)
Stephanie Polazzi
(S)
Antoine Duclos
(A)
Mehdi Benchaib
(M)
Regine Cartier
(R)
Marine Jourdain
(M)
Michelle Ottmann
(M)
Rolf Kramer
(R)
Sylvie Fiorini
(S)
Nathalie Rivat
(N)
Yahia Mekki
(Y)
Julie Fort-Jacquier
(J)
Maud-Catherine Barral
(MC)
Vey Noelie
(V)
Julie Haesebaert
(J)
Come Horvat
(C)
Leo Vidoni
(L)
Jean-Marc Reynes
(JM)
Jean-Francois Eleouet
(JF)
Laurence Josset
(L)
Matthieu Receveur
(M)
Références
J Clin Virol. 2018 May;102:12-18
pubmed: 29471266
Clin Infect Dis. 2021 Feb 17;:
pubmed: 33594407
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
Curr Top Microbiol Immunol. 2013;372:39-57
pubmed: 24362683
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Vaccine. 2018 Oct 29;36(45):6591-6593
pubmed: 30266485
Nat Commun. 2019 Dec 4;10(1):5512
pubmed: 31797866
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30547-30553
pubmed: 33168723
Lancet Respir Med. 2021 Feb;9(2):175-185
pubmed: 32971018
Vaccine. 2016 Jan 4;34(2):190-197
pubmed: 26100926
Emerg Infect Dis. 2021 Feb;27(2):641-643
pubmed: 33263515